Reporter's notebook: House exodus threatens Johnson's grip on power as over 40 members head for exit Cher Scores Near-Complete Victory in Royalties War, Mary Bono Vows Appeal NFL playoff picture 2025: ...

Dave the Diver, the smash hit adventure RPG/management hybrid, is finally available on Xbox. The game, about an intrepid scuba diver named Dave who splits his time between underwater adventuring and ...

MINTROCKET has released an Xbox Series version of single-player adventure RPG DAVE THE DIVER via Microsoft Store for $19.99, the developer announced. The PC version is also now available via Microsoft ...

It’s been a long time coming, but Dave moves at his own pace – Dave the Diver is finally coming to Xbox, and it’s available today. As revealed at the Xbox Partner Showcase, Mintrocket’s blend of ...

Cast your mind back to 2023 and you might recall a lot of PC players getting very excited about a bearded fellow named Dave and his adventures deep below the waves. Well, following Dave the Diver's ...

In late September 2025, an image claiming to show an octopus helping a diver with underwater maintenance tasks began circulating on Facebook. One version (archived), included the following caption: ...

A man died Wednesday after he surfaced from a scuba dive off Pompano Beach and was experiencing a medical emergency, a city official said. The 77-year-old man, an experienced diver with 1,000 previous ...

Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases, eliminating the need for preconditioning chemotherapy. Lead candidate Descartes-08 showed promising ...

LONG BEACH, Calif. (KABC) -- A man died after suffering an unspecified medical emergency during a scuba diving excursion Friday morning off the coast of Long Beach, authorities said.

Cartesian Therapeutics, Inc. has announced the enrollment of the first participant in its Phase 3 AURORA trial for Descartes-08, its lead cell therapy candidate aimed at treating myasthenia gravis (MG ...

Cartesian Therapeutics updates on Descartes-08 trials in myasthenia gravis and lupus, with financial results highlighting $182.1 million in cash. Cartesian Therapeutics, Inc. has announced the ...